Scarica l'app Stockscreener
7.256
0.28%
0.014
Profound Medical Corp Borsa (PROF) Ultime notizie
Profound Medical (PROF) price target decreased by 26.77% to 8.49 - MSN
Profound Medical Corp. (TSE:PRN) Is Expected To Breakeven In The Near Future - Yahoo Finance
Profound Medical Corp (PROF) Q4 2025 Earnings Call Highlights: R - GuruFocus
MSN Money - MSN
Why Medtech Giants Are Quietly Paying Up for AI Diagnostics - Benzinga
Why Medtech Giants Are Quietly Paying Up for AI Diagnostics - Sahm
Profound Medical Showcases TULSA Data, AI Software Upgrades, and Reimbursement Tailwinds at Conference - Yahoo Finance
Profound Medical (TSX:PRN) Stock Price & News - The Motley Fool Canada
Responsive Playbooks and the PROF Inflection - Stock Traders Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp.PROF - FinancialContent
Profound Medical : Investor Presentation (Profound Investor Presentation April 2026 ver9final) - marketscreener.com
Profound Medical : Investor Presentation (Profound Investor Presentation April 2026 ver8final) - marketscreener.com
Profound Medical (PROF) Stock: Year Start (Institutional Demand) 2026-04-20Stock Community Signals - Newser
Profound Medical to Release First Quarter 2026 Financial Results on May 7Conference Call to Follow - Investing News Network
Profound Medical : FY 2025 Management Information Circular - marketscreener.com
Profound Medical Schedules First-Quarter 2026 Earnings Release - TipRanks
Profound Medical to report Q1 2026 results May 7, conference call at 4:30 p.m. ET - TradingView
Profound Medical (NASDAQ: PROF) to report Q1 2026 results, host call May 7 - Stock Titan
Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow - Toronto Star
Profound Medical (PROF) Stock: Momentum Signals (Smart Money Active) 2026-04-15Community Sell Signals - UBND thành phố Hải Phòng
PROF SEC FilingsProfound Med Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Profound Medical Corp. - Mena FN
Stocks in play: Profound Medical Corp. - The Globe and Mail
Profound Medical to Present Business Update at Conference - TipRanks
Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference - The Manila Times
Profound Medical (NASDAQ: PROF) plans business update at 2026 Bloom Burton healthcare investor conference - Stock Titan
Income Plays: Is Profound Medical Corp trading at a discountRisk Management & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Aug Analyst Calls: Is Profound Medical Corp showing insider buying2026 Technicals & Expert-Curated Trade Recommendations - baoquankhu1.vn
Buy Signal: Is Profound Medical Corp in a bullish channel2026 Momentum & Low Risk Growth Stock Ideas - baoquankhu1.vn
Understanding the Setup: (PROF) and Scalable Risk - Stock Traders Daily
If You Invested $1,000 in Profound Med Corp (PROF) - Stock Titan
Rate Cut: What hedge funds are buying Profound Medical Corp2026 Gainers & AI Driven Price Predictions - baoquankhu1.vn
Profound Medical Corp. Investigated by the Portnoy Law Firm - GlobeNewswire
Should I Buy Profound Medical (PROF) Stock Today | Price at $6.42, Down 1.08%Stock Community Signals - Newser
Short Squeeze: Can Profound Medical Corp sustain its profitability2026 Top Gainers & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Forecast Cut: Is Profound Medical Corp being accumulated by smart moneyGlobal Markets & AI Powered Market Entry Strategies - baoquankhu1.vn
Will Profound Medical (PROF) Stock Beat Expectations | Price at $6.85, Up 6.53%Real Trader Insights - Newser
Insider Buying: Profound Medical (TSE:PRN) Director Acquires 20,000 Shares of Stock - MarketBeat
Profound Medical Showcases TULSA-PRO at Key Radiology Meeting - TipRanks
Incision-Free, MRI-Guided Prostate Treatment with Profound's TULSA-PRO to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting - Bitget
Profound Medical’s TULSA-PRO® Incision-Free, MRI-Guided Prostate Treatment Highlighted at 2026 Society of Interventional Radiology Meeting - Minichart
Incision-Free, MRI-Guided Prostate Treatment with Profound's TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting - Investing News Network
Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting - The Manila Times
Profound Medical: TULSA-PRO highlighted in multiple presentations at SIR 2026 - TradingView
TULSA-PRO showcased at SIR 2026 for Profound Medical (NASDAQ: PROF) - Stock Titan
Incision-free prostate treatment lands 7 talks at April medical meeting - Stock Titan
PROF Technical Analysis & Stock Price Forecast - Intellectia AI
Short Interest in Profound Medical (NASDAQ:PROF) Expands By 19.8% - marketbeat.com
Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure Milestone - MarketScreener
Profound Medical (NASDAQ:PROF) Trading Down 1.7%Time to Sell? - marketbeat.com
Profound Medical (TSE:PRN) Stock Price Down 2.6%Time to Sell? - MarketBeat
Income Plays: Is Profound Medical Corp showing insider buyingStop Loss & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Profound Medical Touts Positive Trial Results for MRI-Guided TULSA Procedure - Medical Product Outsourcing
Profound Medical Marks Key TULSA Milestone as Texas Prostate Tops 100 Procedures - tipranks.com
Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone - The Manila Times
0.76%
0.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):